Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.

View source ↗

Summary

A clinical trial is recruiting to evaluate the safety and effectiveness of Beltaven for individuals with bee venom allergy due to Apis mellifera, Polistes domin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beltaven

Snippet

Sponsor: Probelte Pharma S.L.U. | Conditions: Allergy | Status: RECRUITING